```html

Zoster‑induced Cranial Nerve Palsy

What is Zoster‑induced cranial nerve palsy?

Zoster‑induced cranial nerve palsy, also known as herpes zoster ophthalmicus (HZO) with cranial nerve involvement or Ramsay Hunt syndrome type II when the facial nerve is affected, occurs when the varicella‑zoster virus (VZV) reactivates in the sensory ganglia that supply the head and neck. The virus spreads along the cranial nerves, causing inflammation, swelling, and temporary loss of function of the affected nerve. The presentation can range from mild eye irritation to a complete paralysis of a cranial nerve that controls eye movement, facial expression, taste, or hearing.

While the classic rash of shingles is a hallmark sign, a cranial nerve palsy may appear before the rash (a “zoster sine herpete” presentation) or even without any visible lesions, which makes early recognition challenging. Prompt treatment is essential to limit nerve damage and prevent long‑term complications such as persistent facial droop, eye dryness, or permanent vision loss.

Common Causes

Zoster‑induced cranial nerve palsy is not a disease itself but a complication of VZV reactivation. The following factors increase the risk of this complication:

• Prior chicken‑pox infection – The virus remains dormant in dorsal root and cranial ganglia after the initial infection.
• Advanced age – Immunosenescence after age 50 markedly raises reactivation risk.
• Immunosuppression – HIV/AIDS, organ transplantation, chemotherapy, or chronic steroid use.
• Stress or trauma – Physical or emotional stress can trigger viral reactivation.
• Diabetes mellitus – Poor glycemic control impairs cellular immunity.
• Autoimmune diseases – Conditions such as systemic lupus erythematosus or rheumatoid arthritis.
• Radiation therapy to the head/neck – Damages local nerve tissue and immune surveillance.
• Use of biologic agents – Anti‑TNF or JAK inhibitors increase susceptibility.
• Previous episodes of shingles – Recurrence rates rise after an initial episode.
• Age‑related decline in VZV‑specific T‑cell immunity – Even without overt immunosuppression.

Associated Symptoms

The specific symptoms depend on which cranial nerve is involved, but the following are commonly reported:

• Rash or vesicles in the distribution of the ophthalmic branch of the trigeminal nerve (V1) – “hawthorn” or “V1” distribution.
• Eye pain, tearing, photophobia (if V1 or VI is affected).
• Facial droop, inability to close the eye, loss of taste on the anterior 2/3 of the tongue (facial nerve, CN VII).
• Double vision (diplopia) or difficulty moving the eye outward (abducens nerve, CN VI).
• Hearing loss, tinnitus, vertigo (vestibulocochlear nerve, CN VIII) – uncommon but reported in extensive cases.
• Loss of sensation or numbness on the cheek, forehead, or scalp (trigeminal nerve, CN V).
• Severe headache or facial pressure that may mimic sinusitis or migraine.
• Difficulty swallowing or hoarseness (if the glossopharyngeal or vagus nerves are involved).
• General viral prodrome – fever, malaise, chills.

When to See a Doctor

Because nerve damage can become permanent within days, seeking medical care promptly is vital. Contact a healthcare professional if you notice any of the following:

• Sudden facial weakness or drooping, especially if the eye cannot close.
• New‑onset double vision, eye pain, or a visible rash around the eye or forehead.
• Severe, unrelenting headache combined with facial numbness.
• Hearing changes, ringing in the ears, or balance problems.
• Swelling or redness of the eye, blurred vision, or a sensation of a foreign body in the eye.
• Fever > 38 °C (100.4 °F) with the above neurologic signs.

Diagnosis

Clinicians use a combination of history, physical examination, and targeted investigations:

Clinical Evaluation

• History – Recent shingles, immunosuppressive medications, age, systemic illnesses.
• Neurologic exam – Cranial nerve testing (facial symmetry, eye movements, corneal reflex, taste, hearing).
• Skin inspection – Look for vesicular lesions in the V1 distribution; note “zoster sine herpete” if absent.

Laboratory & Imaging

• Polymerase chain reaction (PCR) of lesion swab – Detects VZV DNA, confirming active infection.
• Serology – VZV IgM/IgG may support recent reactivation but is less specific.
• Magnetic Resonance Imaging (MRI) – Useful when the diagnosis is unclear or to rule out alternative causes (stroke, tumor, demyelination).
• CT scan of the orbit – Evaluates for orbital cellulitis or abscess if eye involvement is severe.
• Ophthalmologic exam – Slit‑lamp examination, fluorescein staining to assess corneal damage.

Treatment Options

Early antiviral therapy is the cornerstone of care, combined with supportive measures to protect the eye and improve nerve recovery.

Antiviral Medications

• Acyclovir 800 mg orally five times daily for 7–10 days.
• Valacyclovir 1 g orally three times daily (more convenient dosing).
• Famciclovir 500 mg orally three times daily.
• Intravenous acyclovir (10 mg/kg every 8 h) is reserved for immunocompromised patients or severe ocular involvement.

Initiate antivirals within 72 hours of rash onset for optimal outcomes; however, treatment is still beneficial after this window.

Corticosteroids

Systemic steroids (e.g., prednisone 60 mg daily, tapered over 2–3 weeks) may reduce inflammation and speed functional recovery, particularly for facial nerve palsy. Use only under physician supervision because steroids can worsen infection in immunocompromised hosts.

Eye Care

• Lubricating eye drops or ointments every 2–4 hours to prevent corneal drying.
• Artificial tears during the day; petroleum‑based ointment at night.
• Patch the eye if the eyelid cannot close fully (tarsorrhaphy) to protect the cornea.

Pain Management

• Acetaminophen or ibuprofen for mild‑to‑moderate pain.
• Gabapentin or pregabalin for neuropathic pain that persists beyond the rash.
• Short course of opioids only if pain is severe and uncontrolled.

Physical Therapy & Rehabilitation

• Facial‑exercise programs guided by a speech‑language pathologist for CN VII palsy.
• Eye‑movement exercises for abducens nerve involvement.
• Balance training if vestibular nerves are affected.

Home Care Measures

• Keep the rash clean and dry; apply cool compresses to reduce itching.
• Avoid touching or scratching lesions to prevent secondary bacterial infection.
• Maintain good hydration and a balanced diet to support immune recovery.
• Do not wear contact lenses until an ophthalmologist clears them.

Prevention Tips

Because the underlying trigger is VZV reactivation, prevention focuses on strengthening immunity and reducing viral spread.

• Shingles vaccine – Recombinant zoster vaccine (Shingrix) is recommended for adults ≥ 50 years and for younger adults with immunocompromising conditions. Two doses, 2–6 months apart, provide >90 % efficacy.
• Healthy lifestyle – Regular exercise, adequate sleep (7–9 hours), and a diet rich in fruits, vegetables, and lean protein boost cellular immunity.
• Manage chronic diseases – Keep diabetes, hypertension, and cholesterol under control.
• Avoid smoking and limit alcohol – Both impair immune response.
• Hand hygiene – Reduces transmission of VZV to susceptible individuals (e.g., unvaccinated children).
• Prompt treatment of initial chicken‑pox in children reduces viral load and may lower later reactivation risk.
• Review medications – Discuss with your doctor the risk of long‑term steroids or immunosuppressants; dose‑adjust if possible.

Emergency Warning Signs

Key Take‑aways

• Zoster‑induced cranial nerve palsy is a rare but serious complication of shingles, most often affecting the facial (CN VII) or abducens (CN VI) nerves.
• Early antiviral therapy (within 72 hours) and, when appropriate, corticosteroids dramatically improve recovery odds.
• Protecting the eye—lubrication, patching, and ophthalmology follow‑up—is crucial to prevent permanent vision loss.
• Vaccination with Shingrix is the most effective preventive strategy, especially for adults over 50 or those with weakened immunity.
• Any rapid visual changes, severe eye pain, or inability to close the eye warrant immediate emergency evaluation.

For further reading, consult reputable sources such as the Mayo Clinic, the CDC, and the National Health Service (NHS). Always discuss individual symptoms and treatment options with a qualified healthcare professional.

```